Thank you both for coming.
This is very useful to us, and likewise, Dr. Quinn, thank you for coming forward and for your candour about your struggles. I know this must make things much more difficult for you.
We're talking about the diagnosis of mefloquine toxicity. Right now, we are dealing with a lot of literature that says there are some associations. I haven't been able to pin down anyone for an answer as to how I can look at patient X and say this patient's symptoms are mefloquine toxicity. An Australian committee report tabled in March of 2019 specifically says, “There is no specific way to diagnose chronic mefloquine toxicity effects as many symptoms are shared with other conditions such as PTSD.”
How do we reconcile a statement like that?